CompletedNot Applicable

T3 Versus T4 Sympathicotomy for Treatment of Primary Palmar Hyperhidrosis

Egypt136 participantsStarted 2008-02

Plain-language summary

T3 versus T4 as a primary treatment for palmer hyperhydrosis and effect on postoperative compensatory hyperhydrosis

Who can participate

Age range15 Years – 38 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with primary palmar hyperhidrosis Exclusion Criteria: * Patients with pleural adhesion * Bleeding diathesis * Local infection * Patients with certain anatomic anomalies

What they're measuring

postoperative compensatory hyperhidrosis

Timeframe: 2008-2010

Trial details

NCT IDNCT01295853

SponsorMansoura University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2010-09

View on ClinicalTrials.gov More Compensatory Hyperhidrosis trials